Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Beta-Glucans Is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects Publisher Pubmed



Sadoughi F1 ; Asemi Z1 ; Hallajzadeh J2 ; Mansournia MA3 ; Yousefi B4, 5
Authors

Source: Current Pharmaceutical Biotechnology Published:2022


Abstract

Ovarian cancer is a lethal type of cancer which is initiated to the ovaries and affects 1 out of every 75 women. Due to the high number of deaths (almost 152,000) related to this cancer, it seems that novel efficient therapeutic methods are required in this field. Beta-glucans are a type of glucose linear polymers which have been proven to have a lot of advantageous activities. Recently, investigations have declared that these polysaccharides have the potential to be used as anti-cancer drugs. These agents are able to affect several mechanisms such as inflammation and apoptosis, and that is how cancers are prone to be affected by them. In this review, we attempt to investigate the role of beta-glucans on ovarian cancer. We hope that this paper would give some novel insights into the field of ovarian cancer treatment. © 2022 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Fungal Β-Glucans: Biological Properties, Immunomodulatory Effects, Diagnostic and Therapeutic Applications, Infectious Diseases and Clinical Microbiology (2025)
2. Ovarian Cancer in the World: Epidemiology and Risk Factors, International Journal of Women's Health (2019)
3. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Hamid Reza Mirzaei (1)
Other Related Docs
4. Gata3 Expression in Tumor-Infiltrating Mononuclear Inflammatory Cells Is Associated With Poor Prognostic Factors in Tubo-Ovarian Carcinomas, Pathology International (2024)
5. Modulation of Apoptosis by Melatonin for Improving Cancer Treatment Efficiency: An Updated Review, Life Sciences (2019)
6. Sensitive and Cost-Effective Tools in the Detection of Ovarian Cancer Biomarkers, Analytical Science Advances (2024)
7. Functions, Mechanisms, and Clinical Applications of Lncrna Linc00857 in Cancer Pathogenesis, Human Cell (2023)
8. Silibinin Exerts Anti-Cancer Activity on Human Ovarian Cancer Cells by Increasing Apoptosis and Inhibiting Epithelial-Mesenchymal Transition (Emt), Gene (2022)
9. Strong Evidences of the Ovarian Carcinoma Risk in Women After Ivf Treatment: A Review Article, Iranian Journal of Public Health (2019)
10. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
11. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)
12. Protacs in Gynecological Cancers: Current Knowledge and Future Potential As a Treatment Strategy, Pathology, research and practice (2024)
13. Development of a Bioluminescence Assay for Bir2- Caspase3 Interaction Through Split Luciferase Complementary Assay, Biochemical Engineering Journal (2022)
14. Various Concentrations of Hesperetin Induce Different Types of Programmed Cell Death in Human Breast Cancerous and Normal Cell Lines in a Ros-Dependent Manner, Chemico-Biological Interactions (2023)
15. The Inhibitory Effect of Disulfiram Encapsulated Plga Nps on Tumor Growth: Different Administration Routes, Materials Science and Engineering C (2016)
16. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
17. Overview of Apoptosis, Autophagy, and Inflammatory Processes in Toxoplasma Gondii Infected Cells, Pathogens (2023)
18. The Role of Genistein and Its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications, Current Medicinal Chemistry (2025)
19. Salinomycin Nanoparticles Interfere With Tumor Cell Growth and the Tumor Microenvironment in an Orthotopic Model of Pancreatic Cancer, Drug Development and Industrial Pharmacy (2018)
20. Overview of Cd24 As a New Molecular Marker in Ovarian Cancer, Journal of Cellular Physiology (2019)